Yoo et al. [105] revealed in vivo that serum levels of LECT-2 are increased in individuals with obesity and fatty liver disease, in addition to promoting N-terminal Jun kinase (JNK) phosphorylation in myocytes, leading to impaired insulin sensitivity in mice and an intercorrelation with metabolic syndrome. Here, MAPK8 is linked to fatty liver disease.